JOINT FILER AGREEMENT
EXHIBIT 99.1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
| Dated: August 18, 2020 | SPECTRUM PHARMACEUTICALS, INC., a Delaware corporation
By: /s/ Xxxx X. Xxxxxxxxx Name: Xxxx X. Xxxxxxxxx Title: Executive Vice President and Chief Financial Officer | |
| Dated: August 18, 2020 | SPECTRUM PHARMACEUTICALS CAYMAN, L.P.,
an Exempted Limited Partnership organized under the laws of the Cayman Islands | |
| By: Spectrum Pharmaceuticals International Holdings, LLC Its: General Partner
By: Spectrum Pharmaceuticals, Inc. Its: Managing Member
By: /s/ Xxxx X. Xxxxxxxxx Name: Xxxx X. Xxxxxxxxx Title: Executive Vice President and Chief Financial Officer | ||
